3+ day, 21+ hour ago   (235+ words) Lotus Neuro, a clinical-stage biotechnology company spun out of focused ultrasound specialist Insightec, launched publicly with a platform designed to improve delivery of therapeutics across the blood-brain barrier (BBB). The underlying Insightec technology has already been evaluated clinically in several…...

4+ day, 16+ hour ago   (500+ words) AllSci Researchers at the University of California, Davis have used systematic chemical deconstruction of lysergic acid diethylamide (LSD) to identify which features of its complex molecular architecture are required to produce its characteristic activity at serotonin receptors — findings the authors…...

5+ day, 13+ hour ago   (630+ words) AllSci A new analysis published in Nature Biotechnology adds an unexpected dimension to the clinical profile of rentosertib, the AI-designed TNIK inhibitor from Insilico Medicine (HKEX: 3696) now in Phase III development for idiopathic pulmonary fibrosis: six independently developed proteomic aging…...

2+ week, 5+ day ago   (227+ words) A large language model operating without human input into any individual design decision produced confirmed protein binders against 14 of 15 testable targets, including several considered difficult by conventional computational methods, according to a technical report published August 18, 2026 by Anthropic. Two results…...

2+ week, 5+ day ago   (399+ words) AllSci University of California, Irvine has received a USD 3 million RC2 grant from the National Center for Advancing Translational Sciences (NCATS) to develop a fluorescence lifetime imaging microscopy (FLIM) and machine learning platform designed to improve how drugs are tested against…...

3+ week, 2+ day ago   (320+ words) AllSci San Francisco-based Chai Discovery and Bristol Myers Squibb (NYSE: BMY) have announced a collaboration to apply Chai's generative AI antibody discovery platform across BMS's broader portfolio, with the stated goal of building an AI-powered, continuously learning discovery system at…...

3+ week, 2+ day ago   (86+ words) AI-guided AAV engineering has become an increasingly competitive field. Dyno Therapeutics has established capsid discovery collaborations with Roche and Astellas, with Astellas exercising a license option in April 2026 for an AI-designed skeletal muscle-targeting capsid. Other developers have similarly focused on…...

3+ week, 2+ day ago   (53+ words) Category: Clinical Trial Reform | Regulatory Body: FDA (CBER, CDER, CDRH, OCE) | Geography: United States | Instrument: Guidance document Access the AllSci platform to explore the science behind the news. Have a question or correction on this story? Contact [email protected]. Learn…...

3+ week, 3+ day ago   (132+ words) A prospective, blinded competition involving 29 organizations and 511 AI-designed antibody sequences has producedone of the largest prospective, blinded benchmarks of computational antibody design to date — and found that performance varies so widely across groups and tasks that no single algorithmic approach…...

3+ week, 4+ day ago   (137+ words) Palo Alto-based Network Bio has launched with USD 50 million in financing to build disease-specific AI models trained on multimodal patient tissue, blood, and longitudinal clinical data — a platform the company said is already generating transferable disease signals across conditions it…...